An observational study in Carpal Tunnel Syndrome, sponsored by Jakub Antczak. Completed at 1 site in Poland. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-06.
Sponsored by Jakub Antczak · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this observational study is to test the new kind of ultrasound-based measurements in patients with carpal tunnel syndrome. The main questions it aims to answer are:
Participants will be asked to:
Researchers will compare the group of patients with carpal tunnel syndrome with healthy volunteers to see if respective measurements differ significantly between groups.
Carpal tunnel syndrome (CTS) is the most common compression neuropathy. CTS results from the compression of the median nerve in the carpal tunnel. The main symptoms include pain and other unpleasant sensations in hand and wrist. In more advanced stage, weakness and wasting of the thenar and other muscles innervated by median nerve occurs, which may lead to permanent impairment of manual performance. Nerve conduction studies (NCS) remain the method of choice in diagnosing CTS. However ultrasonography (US) is increasingly used along with or instead of NCS. Most frequently, the increase of the cross-sectional area of the median nerve at the inlet to the carpal tunnel is regarded as the marker of CTS. A number of other measurements such as median nerve mobility, volar bulging of flexor retinaculum and others were also studied to increase diagnostic sensitivity and specificity. In this study the investigators aim to assess the utility of measurements made at the point of the maximal stenosis of the median nerve in the tunnel to diagnose CTS. So far, there were only few studies, which visualized the maximal nerve stenosis, which is the essential pathological feature of CTS. In general, the group of patients with CTS and controls will undergo NCS of symptomatic median and ipsilateral ulnar nerves and US of the symptomatic median nerve with measurements of the cross-sectional area, diameter and echogenicity at various points, including the point of the maximal stenosis. The location of the maximal stenosis with respect to external (distal crease) and internal (wrist and hand bones and thenar musculature) will also be evaluated. Subjects will also be asked to fill out the Boston Carpal Tunnel Questionnaire (BCTQ) and a demographic questionnaire. US measurements will be compared between patients and healthy volunteers. US measurements, especially those made at the point of stenosis will be correlated among patients with clinical severity of CTS, reflected by the score in BCTQ and with the grade of electrophysiological severity as introduced by Padua et al. [1].
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
This study's enrollment of 84 is close to the median of 92 across 131 observational studies indexed under Carpal Tunnel Syndrome.
Browse Carpal Tunnel Syndrome studies →Jakub Antczak is the lead sponsor of 8 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants will be recruited from the patients referred to the EMG Laboratory of the Department of Neurology at Jagiellonian University Medical College for verification of clinical diagnosis of CTS. After NCS and/or US confirms the CTS, the patient will be asked if she/he would like to take part in the study. Healthy controls will be recruited from the patients referred for verification of clinical diagnosis of tetany, after EMG reveals weak tetany or does not confirm it.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients referred to the Electromyographic Laboratory of the Department of Neurology at the Jagiellonian University Medical College, Cracow, Poland with symptoms suggestive of CTS (numbness of the hand, present or accentuated in the night, reduced hand dexterity) with CTS confirmed in NCS or US.
Diagnostic Test: Nerve conduction study · Diagnostic Test: Ultrasound
Subjects referred to the Electromyographic Laboratory of the Department of Neurology at the Jagiellonian University Medical College, Cracow, Poland for investigation towards tetany, with no or only weak signs of tetany in electromyography.
Diagnostic Test: Nerve conduction study · Diagnostic Test: Ultrasound
Nerve conduction study of median and ulnar nerve together with sensory comparative methods on the affected side (sides).
Ultrasound of the median nerve on the affected side (sides).
Difference in the diameter of median nerve in the site of its maximal compression
Difference in the diameter of median nerve in the site of its maximal compression between patients with CTS and healthy controls.
Time frame: Through study completion, an average of 1 year.
Difference in the cross-sectional area of median nerve in the site of its maximal compression
Difference in the cross-sectional area of median nerve in the site of its maximal compression between patients with CTS and healthy controls.
Time frame: Through study completion, an average of 1 year.
Difference in the echogenicity of median nerve in the site of its maximal compression
Difference in the echogenicity of median nerve in the site of its maximal compression between patients with CTS and healthy controls.
Time frame: Through study completion, an average of 1 year.
Correlation of the diameter of median nerve in the site of its maximal compression with BCTQ score
Correlation of the diameter of median nerve in the site of its maximal compression with BCTQ score in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Correlation of the cross-sectional area of median nerve in the site of its maximal compression with BCTQ score
Correlation of the cross-sectional area of median nerve in the site of its maximal compression with BCTQ score in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Correlation of echogenicity of median nerve in the site of its maximal compression with BCTQ score
Correlation of echogenicity of median nerve in the site of its maximal compression with BCTQ score in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Correlation of the diameter of median nerve in the site of its maximal compression with CTS electrophysiological severity grade
Correlation of the diameter of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Correlation of the cross-sectional area of median nerve in the site of its maximal compression with CTS electrophysiological severity grade
Correlation of the cross-sectional area of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Correlation of echogenicity of median nerve in the site of its maximal compression with CTS electrophysiological severity grade
Correlation of echogenicity of median nerve in the site of its maximal compression with CTS electrophysiological severity grade in patients with CTS.
Time frame: Through study completion, an average of 1 year.
Plan to share: Yes — After completing the study, the age and gender of participants as well as the scores of BCTQ, the results of NCS and the US images in .jpg and .dicom will be available to other researchers on request.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: The data will become available after the study results will be published.
Access criteria: On request sent by e-mail to jakub.antczak@uj.edu.pl
Ran from Nov 2023 to primary completion in Feb 2024, 3 months.
Of 40 non-industry observational studies under Carpal Tunnel Syndrome, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's 3 months is below that.
Counting every sponsor, half of 42 studies reached it within 18 months; a quarter within 11 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jakub Antczak